ICLR

ICON plc
D

ICLR

163.250
USD
-5.41
(-3.21%)
مفتوح الان
حجم التداول
16,579
الربح لكل سهم
14
العائد الربحي
-
P/E
17
حجم السوق
13,193,988,580
أصول ذات صلة
NEOUSD
NEOUSD
0.05458
(1.19%)
4.66003 USD
B
BIO
-9.440
(-3.84%)
236.130 USD
C
CRL
-9.000
(-6.03%)
140.360 USD
DGX
DGX
2.610
(1.55%)
170.520 USD
ILMN
ILMN
-4.010
(-4.90%)
77.810 USD
LH
LH
-1.160
(-0.49%)
235.220 USD
MTD
MTD
-75.31
(-6.41%)
1,099.44 USD
N
NEO
-0.49000
(-5.21%)
8.92000 USD
Q
QDEL
-1.660
(-4.80%)
32.940 USD
TMO
TMO
-14.82
(-3.03%)
474.64 USD
WST
WST
-1.610
(-0.73%)
220.000 USD
المزيد
الأخبار المقالات

العنوان: ICON plc

القطاع: Healthcare
الصناعة: Diagnostics & Research
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.